-+ 0.00%
-+ 0.00%
-+ 0.00%

Saisheng Pharmaceutical announced that the 8.748 million shares of the company's shares held by Liu Shuqin, the company's original shareholder during her birth, have completed a non-transactional transfer, which was inherited by her daughter, Ma Li, the controlling shareholder of the company and the actual controller Ma Li. The transfer date is November 17, 2026. After the transfer was completed, the number of shares held by Ma Li increased to 32.1848 million shares, accounting for 4.87% to 6.68% of the company's total share capital; Liu Shuqin no longer holds shares in the company. This change in equity is an inheritance. It will not cause a change in the controlling shareholder or actual controller of the company, and does not involve a change in the company's control.

Zhitongcaijing·11/19/2026 11:25:07
Listen to the news
Saisheng Pharmaceutical announced that the 8.748 million shares of the company's shares held by Liu Shuqin, the company's original shareholder during her birth, have completed a non-transactional transfer, which was inherited by her daughter, Ma Li, the controlling shareholder of the company and the actual controller Ma Li. The transfer date is November 17, 2026. After the transfer was completed, the number of shares held by Ma Li increased to 32.1848 million shares, accounting for 4.87% to 6.68% of the company's total share capital; Liu Shuqin no longer holds shares in the company. This change in equity is an inheritance. It will not cause a change in the controlling shareholder or actual controller of the company, and does not involve a change in the company's control.